Pharmaceutical Preparations · DE · CIK 1811063
Nuvation Bio Inc. is a global oncology company developing novel small molecule therapies for cancer
Comparable business profile · signals at a glance
In the 90 days to Dec 1, 2025: 3 sold $6.2M.
| Date | Insider | Action | Shares | Price | Value |
|---|---|---|---|---|---|
| Dec 1, 2025 | Liu DongfangCHIEF MEDICAL OFFICER | Sell | 150,000 | $7.82 | $1.2M |
| Nov 26, 2025 | Liu DongfangCHIEF MEDICAL OFFICER | Sell | 10,000 | $8.00 | $80K |
| Nov 25, 2025 | Liu DongfangCHIEF MEDICAL OFFICER | Sell | 10,000 | $7.50 | $75K |
| Nov 20, 2025 | Hattersley GaryCHIEF SCIENTIFIC OFFICER | Sell | 300,000 | $7.23 | $2.2M |
| Nov 20, 2025 | Hattersley GaryCHIEF SCIENTIFIC OFFICER | Sell | 69,051 | $7.23 | $499K |
| Nov 20, 2025 | Liu DongfangCHIEF MEDICAL OFFICER | Sell | 20,000 | $7.00 | $140K |
| Nov 19, 2025 | Hanley David C.CHIEF TECHNICAL OPERATIONS | Sell | 200,000 | $7.14 | $1.4M |
| Nov 19, 2025 | Liu DongfangCHIEF MEDICAL OFFICER | Sell | 15,000 | $5.10 | $77K |
| Nov 17, 2025 | Liu DongfangCHIEF MEDICAL OFFICER | Sell | 15,000 | $4.77 | $72K |
| Oct 27, 2025 | Hattersley GaryCHIEF SCIENTIFIC OFFICER | Sell | 100,000 | $5.02 | $502K |
Open-market buys & sells (Form 4, transaction codes P/S). Source: SEC structured insider data.